Следене
Puthen Veettil Jithesh
Puthen Veettil Jithesh
Hamad Bin Khalifa University (HBKU)
Потвърден имейл адрес: hbku.edu.qa
Заглавие
Позовавания
Позовавания
Година
Depletion of human DNA in spiked clinical specimens for improvement of sensitivity of pathogen detection by next-generation sequencing
MR Hasan, A Rawat, P Tang, PV Jithesh, E Thomas, R Tan, P Tilley
Journal of clinical microbiology 54 (4), 919-927, 2016
1962016
The Bethesda handbook of clinical oncology
J Abraham, JL Gulley
Lippincott Williams & Wilkins, 2022
1492022
The epigenetic landscape of oral squamous cell carcinoma
PV Jithesh, JM Risk, AG Schache, J Dhanda, B Lane, T Liloglou, RJ Shaw
British journal of cancer 108 (2), 370-379, 2013
1202013
ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer
S Van Schaeybroeck, M Kalimutho, PD Dunne, R Carson, W Allen, ...
Cell reports 7 (6), 1940-1955, 2014
1092014
Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway
L McClements, A Yakkundi, A Papaspyropoulos, H Harrison, MP Ablett, ...
Clinical cancer research 19 (14), 3881-3893, 2013
722013
Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer
C Grills, PV Jithesh, J Blayney, SD Zhang, DA Fennell
PloS one 6 (1), e14635, 2011
722011
Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy
WL Allen, PD Dunne, S McDade, E Scanlon, M Loughrey, HG Coleman, ...
JCO precision oncology 2, 1-15, 2018
662018
Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancer
L Stevenson, WL Allen, R Turkington, PV Jithesh, I Proutski, G Stewart, ...
Clinical cancer research 18 (19), 5412-5426, 2012
622012
Three copies of four interferon receptor genes underlie a mild type I interferonopathy in Down syndrome
XF Kong, L Worley, D Rinchai, V Bondet, PV Jithesh, M Goulet, ...
Journal of clinical immunology 40, 807-819, 2020
482020
Total Proteome Analysis Identifies Migration Defects as a Major Pathogenetic Factor in Immunoglobulin Heavy Chain Variable Region (IGHV)-unmutated Chronic Lymphocytic Leukemia*[S]
GL Eagle, J Zhuang, RE Jenkins, KJ Till, PV Jithesh, K Lin, GG Johnson, ...
Molecular & Cellular Proteomics 14 (4), 933-945, 2015
462015
A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancer
WL Allen, L Stevenson, VM Coyle, PV Jithesh, I Proutski, G Carson, ...
Molecular cancer therapeutics 11 (1), 119-131, 2012
432012
FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy
HD McKeen, C Byrne, PV Jithesh, C Donley, A Valentine, A Yakkundi, ...
Cancer research 70 (3), 1090-1100, 2010
432010
Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen
C Donley, K McClelland, HD McKeen, L Nelson, A Yakkundi, PV Jithesh, ...
Oncogene 33 (26), 3441-3450, 2014
422014
Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo
AG Manente, D Valenti, G Pinton, PV Jithesh, A Daga, L Rossi, SG Gray, ...
Oncogenesis 2 (9), e72-e72, 2013
412013
Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma
D Barbone, L Van Dam, C Follo, PV Jithesh, SD Zhang, WG Richards, ...
PLoS One 11 (3), e0150044, 2016
402016
Whole genome sequencing in the Middle Eastern Qatari population identifies genetic associations with 45 clinically relevant traits
G Thareja, Y Al-Sarraj, A Belkadi, M Almotawa, ...
Nature Communications 12 (1), 1250, 2021
382021
Qatar genome: Insights on genomics from the Middle East
H Mbarek, G Devadoss Gandhi, S Selvaraj, W Al‐Muftah, R Badji, ...
Human mutation 43 (4), 499-510, 2022
362022
Ran GTPase promotes cancer progression via Met receptor-mediated downstream signaling
HF Yuen, KK Chan, A Platt-Higgins, ELH Dakir, KB Matchett, YA Haggag, ...
Oncotarget 7 (46), 75854, 2016
312016
AKT1 has dual actions on the glucocorticoid receptor by cooperating with 14-3-3
T Habib, A Sadoun, N Nader, S Suzuki, W Liu, PV Jithesh, T Kino
Molecular and cellular endocrinology 439, 431-443, 2017
292017
Temple-baraitser syndrome and zimmermann-laband syndrome: one clinical entity?
A Mégarbané, R Al-Ali, N Choucair, M Lek, E Wang, M Ladjimi, CM Rose, ...
BMC medical genetics 17, 1-11, 2016
292016
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20